Treace Medical Stock Options Expiring on 21st of March
| TMCI Stock | USD 8.25 0.03 0.36% |
Treace Medical's latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 3.87 with a put-to-call open interest ratio of 0.06 over 12 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on March 21st 2025.
Open Interest Against March 21st 2025 Option Contracts
2025-03-21
The chart above shows Treace Medical's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Treace Medical's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Treace Medical's option, there is no secondary market available for investors to trade.
Treace Medical Concepts In The Money Call Balance
When Treace Medical's strike price is surpassing the current stock price, the option contract against Treace Medical Concepts stock is said to be in the money. When it comes to buying Treace Medical's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Treace Medical Concepts are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Treace Current Options Market Mood
Treace Medical's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Treace Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Treace Medical's options investors are not very successful. Treace Medical's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Treace contract
Base on the Rule 16, the options market is currently suggesting that Treace Medical Concepts will have an average daily up or down price movement of about 0.24% per day over the life of the 2025-03-21 option contract. With Treace Medical trading at USD 8.25, that is roughly USD 0.02. If you think that the market is fully incorporating Treace Medical's daily price movement you should consider buying Treace Medical Concepts options at the current volatility level of 3.87%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Treace |
Treace Medical Option Chain
When Treace Medical's strike price is surpassing the current stock price, the option contract against Treace Medical Concepts stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Treace Medical's option chain is a display of a range of information that helps investors for ways to trade options on Treace. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Treace. It also shows strike prices and maturity days for a Treace Medical against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | TMCI250321C00015000 | 0 | 15.0 | 0.0 - 0.75 | 0.75 | |
Call | TMCI250321C00012500 | 25 | 12.5 | 0.0 - 1.3 | 0.15 | Out |
Call | TMCI250321C00010000 | 304 | 10.0 | 0.0 - 0.25 | 0.13 | Out |
Call | TMCI250321C00007500 | 14 | 7.5 | 0.0 - 1.7 | 3.1 | In |
Call | TMCI250321C00005000 | 19 | 5.0 | 2.85 - 3.7 | 3.4 | In |
Call | TMCI250321C00002500 | 0 | 2.5 | 4.4 - 6.3 | 4.4 | In |
Put | TMCI250321P00015000 | 0 | 15.0 | 6.3 - 7.6 | 6.3 | In |
Put | TMCI250321P00012500 | 0 | 12.5 | 3.8 - 5.4 | 3.8 | In |
Put | TMCI250321P00010000 | 2 | 10.0 | 1.3 - 2.6 | 1.96 | In |
Put | TMCI250321P00007500 | 4 | 7.5 | 0.0 - 1.25 | 1.52 | Out |
Put | TMCI250321P00005000 | 17 | 5.0 | 0.0 - 0.05 | 0.05 | Out |
Put | TMCI250321P00002500 | 0 | 2.5 | 0.0 - 0.75 | 0.75 |
Treace Medical Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Treace Total Stockholder Equity
Total Stockholder Equity |
|
Treace Medical Corporate Management
| Shana Zink | Senior Reimbursement | Profile | |
| Julie Dewey | Chief Officer | Profile | |
| Scot JD | Chief Secretary | Profile | |
| Thomas Timbie | Independent Director | Profile | |
| John Treace | Founder CEO | Profile | |
| Sean Scanlan | Chief Officer | Profile | |
| Guy Guglielmino | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share | Quarterly Revenue Growth 0.104 | Return On Assets | Return On Equity |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.